“…This was the case for the majority of the included studies, for which exercise took place with concentrations around 10 mmol/L or above: Soo et al [36] (approximate range 12-13 mmol/L), Rabasa-Lhoret et al [35] (50 % V0 2max trial arm [10.7 ± 0.7 mmol/L, mean ± SEM]), Yamanouchi et al [37] (~ 10 mmol/L pre-prandial and ~ 15 mmol/L post-prandial), Peter et al [34] (approximate range 11-12 mmol/L), Guelfi et al [29] (10.9 ± 1.9 mmol/L for REST and 11.0 ± 1.8 mmol/L for IHE, mean ± SD), Guelfi et al [30] (11.0 ± 2.3 mmol/L for CONT and 11.5 ± 3.9 mmol/L for IHE, mean ± SD), and Yardley et al [28] (CONT trial arm [~ 10 mmol/L]). Other studies commenced at more restrained glycemia levels: Jankovec et al [32] (approximate range 7-8 mmol/ L), Rabasa-Lhoret et al [35] (8.8 ± 0.55 mmol/L for their 25 % V0 2ma x trial and 8.5 ± 1.3 mmol/L for 75 % V0 2max , mean ± SEM), and Yardley et al [28] (RESIST trial arm ~8.5 mmol/L). Information in this regard was not provided in Maran et al [33], whereas Iscoe and Riddell [31] mentioned an absolute fall of approximately -5 mmol/L and ~ 50 % relative decay, although data were not reported explicitly in either text or graphs.…”